The Maryland and District of Columbia Society of Clinical Oncology, Inc. (“MDCSCO”) is committed to improving the quality and delivery of care in medical oncology in the State of Maryland and the District of Columbia. We promote appropriate standards of care in oncology and cooperate with investigators conducting cancer research.

In addition, we assist in the continuing education of oncologists and educate the public, the government, insurance carriers, and other health care providers about appropriate prevention of cancer and other therapeutic options for patients with cancer.

We encourage you to join more than 250 current members in providing the leadership in our progressive future. Click here to find out more about our membership.

Click to see the latest News & Publications


Membership Benefits

Membership is Now FREE for
Members and for Allied

Click here to join!




The Maryland and District of Columbia  Society of Clinical Oncology now offers FREE professional memberships to physician oncologists. Click here for the flyer.

As a member, you get the following benefits:

  • Free attendance at ALL MDCSCO events.
  • A legislative voice on issues of high priority to the practice of oncology.
  • Being a member of one of the U.S.'s strongest ASCO state affiliates and representation at ASCO.
  • Representation at NCCN.
  • Opportunity to be considered for elected office and other leadership roles within MDCSCO.

Confirm your membership now!



CMS Releases Physician Fee Schedule Final Rule
The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.



November 14, 2018 - CME Event
Gary Cohen, MD, FACP, FASCO
Director Emeritus, Sandra and Malcolm Berman Cancer Institute
Associate Professor
Johns Hopkins Oncology

Topic: The Transition from Biologics to Biosimilars in Oncology Treatment Paradigms
A Means to Reduce Healthcare Costs with Continued Effective Management of Patients

Location: Baltimore Marriott Inner Harbor at Camden Yards
Promenade Room
110 S. Eutaw Street
Baltimore, MD

CME : 1 Credit

6:30 - Reception
7:30 - Dinner followed by Program

No charge to MDCSCO members
Open to industry, but no displays


Industry Spotlight
December 5, 2018
6:15 pm - 9:45 pm
Session with Board for Platinum, Emerald, and Diamond Corporate  Members Only
Hotel at Arundel Preserve
7795 Arundel Mills Blvd.
Hanover, MD

[email protected]


Click here for more.

Make connections that drive hematology and your career forward.

With more than 25,000 attendees, the ASH annual meeting is the best place to connect with hematology professionals from around the world. It’s not uncommon for connections made at the meeting to lead to new jobs, research opportunities, or important collaborations that help advance the field of hematology.

But what are the best opportunities for networking at the ASH annual meeting?

 Quality Payment Program: 2018 CME Modules, Infographics, and Scoring Guide

The Centers for Medicare & Medicaid Services (CMS) posted three new Continuing Medical Education (CME) modules on the Medicare Learning Network Learning Management System for the 2018 Merit-based Incentive Payment System (MIPS), Click here to see more.